These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39041639)

  • 1. Safety of intravitreally delivered AAV2 vector-mediated multi-characteristic opsin genetic construct in wild type beagle dogs.
    Mohanty S; Batabyal S; Ayyagari A; Sharif NA
    J Gene Med; 2024 Jul; 26(7):e3720. PubMed ID: 39041639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Characteristic Opsin Therapy to Functionalize Retina, Attenuate Retinal Degeneration, and Restore Vision in Mouse Models of Retinitis Pigmentosa.
    Batabyal S; Kim S; Carlson M; Narcisse D; Tchedre K; Dibas A; Sharif NA; Mohanty S
    Transl Vis Sci Technol; 2024 Oct; 13(10):25. PubMed ID: 39412768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.
    Boye SL; Bennett A; Scalabrino ML; McCullough KT; Van Vliet K; Choudhury S; Ruan Q; Peterson J; Agbandje-McKenna M; Boye SE
    J Virol; 2016 Apr; 90(8):4215-4231. PubMed ID: 26865709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of adeno-associated virus type 2 carrying multi-characteristic opsin in dogs following intravitreal injection.
    Tchedre KT; Batabyal S; Galicia M; Narcisse D; Mustafi SM; Ayyagari A; Chavala S; Mohanty SK
    J Cell Mol Med; 2021 Sep; 25(18):8676-8686. PubMed ID: 34418301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach.
    Mowat FM; Gornik KR; Dinculescu A; Boye SL; Hauswirth WW; Petersen-Jones SM; Bartoe JT
    Gene Ther; 2014 Jan; 21(1):96-105. PubMed ID: 24225638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
    Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
    Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose Range Finding Studies with Two
    Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS
    Hum Gene Ther; 2020 Jul; 31(13-14):743-755. PubMed ID: 32414297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized
    Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA
    Hum Gene Ther; 2020 Feb; 31(3-4):253-267. PubMed ID: 31910043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia.
    Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C
    Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
    Woodard KT; Liang KJ; Bennett WC; Samulski RJ
    J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AAV2.7m8 capsid packages a higher degree of heterogeneous vector genomes than AAV2.
    Cui M; Su Q; Yip M; McGowan J; Punzo C; Gao G; Tai PWL
    Gene Ther; 2024 Sep; 31(9-10):489-498. PubMed ID: 39134629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Method Combining Vitreous Aspiration and Intravitreal AAV2/8 Injection Results in Retina-Wide Transduction in Adult Mice.
    Da Costa R; Röger C; Segelken J; Barben M; Grimm C; Neidhardt J
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5326-5334. PubMed ID: 27784063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of intravitreally delivered capsid mutant AAV2-Cre vector to induce tissue-specific mutations in murine retinal ganglion cells.
    Langouet-Astrie CJ; Yang Z; Polisetti SM; Welsbie DS; Hauswirth WW; Zack DJ; Merbs SL; Enke RA
    Exp Eye Res; 2016 Oct; 151():61-7. PubMed ID: 27481653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Photoreceptor Transduction Efficacy of Capsid-Modified Adeno-Associated Viral Vectors Following Intravitreal and Subretinal Delivery in Sheep.
    Ross M; Obolensky A; Averbukh E; Ezra-Elia R; Yamin E; Honig H; Dvir H; Rosov A; Hauswirth WW; Gootwine E; Banin E; Ofri R
    Hum Gene Ther; 2020 Jul; 31(13-14):719-729. PubMed ID: 32486858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection.
    Wassmer SJ; Carvalho LS; György B; Vandenberghe LH; Maguire CA
    Sci Rep; 2017 Mar; 7():45329. PubMed ID: 28361998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman Primates.
    Tshilenge KT; Ameline B; Weber M; Mendes-Madeira A; Nedellec S; Biget M; Provost N; Libeau L; Blouin V; Deschamps JY; Le Meur G; Colle MA; Moullier P; Pichard V; Rolling F
    Hum Gene Ther Methods; 2016 Jun; 27(3):122-34. PubMed ID: 27229628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice.
    Barker SE; Broderick CA; Robbie SJ; Duran Y; Natkunarajah M; Buch P; Balaggan KS; MacLaren RE; Bainbridge JW; Smith AJ; Ali RR
    J Gene Med; 2009 Jun; 11(6):486-97. PubMed ID: 19340848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosidic enzymes enhance retinal transduction following intravitreal delivery of AAV2.
    Cehajic-Kapetanovic J; Le Goff MM; Allen A; Lucas RJ; Bishop PN
    Mol Vis; 2011; 17():1771-83. PubMed ID: 21750604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin.
    Ye GJ; Budzynski E; Sonnentag P; Miller PE; Sharma AK; Ver Hoeve JN; Howard K; Knop DR; Neuringer M; McGill T; Stoddard J; Chulay JD
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):165-76. PubMed ID: 26390090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.